Stay updated with breaking news from Nasdaq Sls. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 3,120,000 shares, a decrease of 19.6% from the January 15th total of 3,880,000 shares. Based on an average daily trading volume, of 990,800 shares, […]
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical...
SELLAS Life Sciences Group (NASDAQ:SLS – Get Free Report) and Imunon (NASDAQ:IMNN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Risk and Volatility SELLAS Life Sciences […]
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Free Report) – Investment analysts at Cantor Fitzgerald lowered their FY2023 earnings per share estimates for SELLAS Life Sciences Group in a research report issued to clients and investors on Monday, November 13th. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings of ($1.04) […]
The stock of SELLAS Life Sciences Group Inc (NASDAQ: SLS) has decreased by -2.70 when compared to last closing price of 0.91.Despite this, the company has seen a loss of -8.53% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-17 that NEW YORK, Oct. 17, 2023 (GLOBE N